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Epigenetic shielding: 5-hydroxymethylcytosine and 5-carboxylcytosine modulate UV 
induction of DNA photoproducts 
Abstract 
Maintaining the balance between dynamic DNA methylation and demethylation is crucial 
to mammalian development and pathogenesis.  In vitro methylation at the C-5 position of 
cytosine enhances cyclobutane pyrimidine dimer (CPD) formation and promotes transition 
mutations. While the loss of 5-hydroxymethylcytosine (5hmC) and inactivation of the ten-eleven 
translocation (TET) family have been implicated in cancers, and repeated exposure to UV 
radiation is a known risk factor for developing skin cancers, the link between DNA 
demethylation and UV damage has not yet been illustrated. We report that hydroxylation and 
carboxylation of 5-methylcytosine mitigate methylation-induced CPD enhancement upon UV 
irradiation. However, 5hmC also increases UV induction of (6-4) photoproducts. In a melanoma 
cell model, this duality by 5hmC in modulating the UV response is accentuated through TET2 
overexpression. These findings implicate the DNA demethylation intermediates 5-
hydroxymethylcytosine (5hmC) and 5-carboxylcytosine (5caC) as selective epigenetic shields 
against UV induction of DNA photoproducts.  
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CHAPTER ONE: INTRODUCTION 
 
UV Light and Skin Cancers 
UV is a powerful extrinsic regulator of skin pigmentation; repetitive UV exposure can 
also induce skin thickening, wrinkle formation, and inflammation. Furthermore, repeated 
exposure to UV radiation from sunlight leads to an increased risk of developing skin cancers. UV 
radiation can be divided into three types: UVA (long-range UV, 320-400nm), UVB (sunburn 
radiation, 280-320nm), and UVC (short-wave UV, 200-280nm) (Cotton and Spandau, 1997; Paz 
et al., 2008). UVC radiation is completely absorbed in the stratosphere by oxygen to produce 
ozone (Brash et al., 1991), and while most of UVB light should also be absorbed before reaching 
the earth’s surface, gradual ozone depletion has let more UVB radiation pass through the 
atmosphere. This trend is especially concerning, since UVB is “responsible for most of the 
carcinogenic effects of sun exposure” (Cotton and Spandau, 1997), and failure to eliminate UV-
damaged cells through controlled apoptosis may result in disease states such as skin cancer or 
lead to faster aging of the skin.  
Repeated exposure to UV radiation from sunlight increases the risk of developing three 
types of skin cancer: Malignant melanoma, basal cell carcinoma (BCC) and squamous cell 
carcinoma (SCC). While melanoma arises from the pigment-producing melanocytes in skin, non-
melanoma skin cancers arise from keratinocytes. Squamous keratinocytes near the top of the 
epidermis can become cancerous, leading to squamous cell carcinoma; basal cells in the bottom 
layer of keratinocytes can also become cancerous, leading to basal cell carcinoma. Basal cell 
cancer is the most common, accounting for 80% of all skin cancers (American Cancer Society, 
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2008 Reference); BCC occurs most frequently (about one million new cases per year) as a hard, 
raised, red wound on the head, neck and other sun-exposed areas, and usually does not 
metastasize, but can recur. Squamous cell cancer is less common (about 200,000 new cases per 
year), but more aggressive and can invade nearby tissues; SCC is the most sunlight-dependent 
type of skin cancer, since the majority of invasive squamous cell carcinomas are marked by 
cytosine to thymine UVB signature mutations (Brash et al., 1991). Malignant melanoma occurs 
even more rarely (about 50,000 new cases per year), but is the most serious type of skin cancer, 
usually metastasizing unless detected early (American Cancer Society, 2008 Reference; Cleaver 
and Crowley, 2002).  
 
UV Lesions and DNA Mutations  
When UV radiation damages a cell, it mutates the cellular DNA with distinctive 
mutational patterns. The major UV lesions produced are pyrimidine dimers between adjacent 
pyrimidines (Gale et al., 1987), resulting in a four membered ring from covalent linkages of the 
carbon-carbon double bonds on pyrimidines (Illustration 1). These cyclobutane pyrimidine 
dimers (CPDs) are quite mutagenic, especially in mammalian cells, initiating primary base 
substitutions in DNA (Otoshi et al., 2000). UV-light most dominantly induces cytosine to 
thymine transitions at the dipyrimidine sites, creating a UV-specific mutation signature that is 
ubiquitously observed in multiple organisms (Brash et al., 1991). The presence of CC to TT 
mutations uniquely identifies UV as the mutagen, since these double base changes are 
exclusively due to direct UV light absorption (Brash et al., 1991).  
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Illustration 1: TT CPD dimer formation (as published in Liu and Fisher, 2010 review) 
The induction yield for CPDs depends on sequence specificity, as well as the wavelength 
of UV. 5’ guanine inhibited CPD induction, while 3’ guanine enhanced CPD induction, and CPD 
induction was also greater in the presence of 5’ flanking pyrimidines (Cannistraro and Taylor, 
2009; Mitchell et al., 1991). Furthermore, the frequency of CPD formation oscillates along the 
core DNA, with maximum CPD formation within one base of sites where the DNA backbone is 
farthest from the surface of core histones, and minimum CPD formation at sites where the DNA 
backbone is closest to the surface of core histones (Gale et al., 1987). UVB radiation produces 
most of the CPD photoproducts in mammalian skin compared to UVA, which comprises most of 
sunlight radiation at the Earth’s surface; UVC is even more potent and lethal, “but it is screened 
out at least 105-fold by the ozone layer” (Brash et al., 1991), and thus a minimal source of health 
hazards (Tran et al., 2008). From in vitro studies of UV irradiations in plasmids, the following 
induction rates were observed: 2.4 CPDs per 108 daltons of DNA per J/m2 UVC; 0.3 CPDs per 
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108 daltons of DNA per J/m2 UVB (Mitchell et al., 1991). While TT CPDs are the most 
abundant, TC or CT CPDs are more abundant than CC CPDs, with ratios ranging from 60:24:16 
(UVC) to 68:29:3 (UVC), 40:40:20 (UVB) and 52:40:7 (UVB) (Mitchell et al., 1991). It has 
been suggested that cytosine-containing dimerized pyrimidines are more mutagenic than TT 
dimers; since UVB induces more cytosine containing dimers, the mutational spectrum of UVB 
contains more deletions, insertions and C to T transition mutations at dipyrimidine sites than the 
mutational spectrum of UVC (Mitchell et al., 1991). 	   
The high incidence of p53 mutations at dipyrimidine sites in skin tumors correlates well 
with the presence of UV-induced mutagenic photoproducts (Tran et al., 2008).  The p53 tumor 
suppressor gene controls the stress and genetic-damage response pathway (Alberts et al., 2002). 
Loss of normal p53 function not only allows abnormal cells to avoid programmed cell death, but 
also enables cells to accumulate additional mutations at a rapid rate by allowing abnormal cells 
to progress through the cell cycle and thus create many abnormal chromosomes (Alberts et  al., 
2002). The p53 protein can be activated by a variety of stress signals, including sources that 
damage the integrity of the DNA template, such as gamma or UV irradiation, alkylation of bases, 
depurination of DNA and reaction with oxidative free radicals. In a study of patients from New 
England and Sweden (Brash et al., 1991), 58% of invasive squamous cell carcinomas (SCC) 
were marked by cytosine to thymine transitions (C -> T and CC -> TT) in the p53 gene.  
 
DNA Photoproducts 
While cyclobutane pyrimidine dimers (CPDs) are responsible for the majority of UVB-
induced mutations in mammalian cells, UVB and UVC can also induce (6-4) photoproducts, 
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another type of DNA damage formed between adjacent pyrimidine nucleotides on the same 
strand of DNA (Illustration 2). Both the yield and the ratio between CPDs and (6-4) 
photoproducts (6-4 PPs) upon UV irradiation vary greatly, depending on the chemical nature of 
the two pyrimidine bases involved, as well as other parameters such as the wavelength of the 
incident photons, the stability of the duplex DNA, and the ionic strength (Douki, 2006). The 
structure of the thymine-cytosine (6-4) photoproduct, the most abundant type of 6-4 PPs, was 
deduced by proton NMR, IR and fast atom bombardment mass spectroscopy (Franklin et al., 
1985). While both CPDs and 6-4 PPs are premutagenic lesions for cytosine to thymine 
transitions, 6-4 PPs are also premutagenic lesions for thymine to cytosine transitions (LeClerc et 
al., 1991; Otoshi et al., 2000).  
 
Illustration 2: TC 6-4 PP (with J. Babcock, JHU) 
Under near UV irradiation around 320nm, 6-4 PPs photoisomerize to Dewar valence 
isomers. Two major synthesis steps are required for generating Dewar photoproduct-containing 
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oligonucleotides: Short oligomers with a unique thymine-thymine sequence are irradiated under 
UVC (254nm), upon which TT 6-4 PPs are purified by HPLC; next, these oligomers are 
irradiated at the longer wavelengths to produce Dewar isomers (Yamamoto et al., 2006). Dewar 
isomers are much more unstable than 6-4 PPs (Kan et al., 1992). Compared to the highly 
mutagenic 6-4 PPs, Dewar photoproducts also have low mutagenic potential and induce a 
broader range of mutations (LeClerc et al., 1991; Lee et al., 2000).  
 
Epigenetic Status and UV Induction 
As described above, C to T or CC to TT mutations (CPD signature mutations), have been 
found in the p53 gene in a large percentage of human basal and squamous cell carcinomas. 
Interestingly, recent technical advances have helped reveal that over a third of these p53 
mutations involve 5’PymeCG trinucleotide sequences with the modified 5-methylcytosine 
(5meC) base (Tornaletti and Pfeifer, 1995; You and Pfeifer, 2001; Lee and Pfeifer, 2003; 
Cannistraro and Taylor, 2009). This correlates with observations in cultured mammalian cells 
that 5-methylcytosine-containing dipyrimidines are preferential targets for sunlight-induced 
mutagenesis (Tommasi et al., 1997). One widely accepted hypothesis for the C to T transition 
process at dipyrimidine sequences involves the deamination of cytosine or 5-methylcytosine, 
followed by trans-lesion synthesis. Previous in vitro studies using chromatography, mass-
spectrometry, enzymatic analysis, and ligation-mediated PCR have shown that methylation at the 
C-5 position of cytosine enhances CPD formation (under both broadband and monochromatic 
UVB) and promotes deamination, leading to increased UVB-induced C to T transition mutations 
(Douki and Cadet, 1994; Tommasi et al., 1997; You et al., 1999; Douki et al., 2000; Mitchell, 
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2000; Cannistraro and Taylor, 2009; Rochette et al., 2009). From a structural consideration, 5-
methylcytosine enhances the dimerization reaction with the adjacent 3’ end cytosine residue. 
Cytosine methylated at the C-5 position has a significantly lower excited singlet energy state 
than thymine or normal cytosine, and thus 5-methylcytosine could serve as a singlet energy trap 
in DNA (Tommasi et al., 1997). 
 
The “Sixth Base” and Beyond 
 5-methylcytosine can be converted by the TET machinery (ten-eleven translocation 
family of 5meC hydroxylases) into the newly (re)discovered “sixth base”, 5-
hydroxmethylcytosine (5hmC). The (re)discovery of 5hmC was actually an accidental finding 
during measurements of 5-methylcytosine: Thin-layer chromatography, high-pressure liquid 
chromatography, and mass spectrometry revealed an unusual DNA nucleotide, now known as 
5hmC, that constitutes less than 1% of total nucleotides in neuronal cells and is not present in 
cancer cell lines (Kriaucionis and Heintz, 2009). The existence of 5hmC has been known in the 
bacteriophage world since the early 1950s (Wyatt and Cohen, 1952). The discovery of 5hmC in 
mammalian DNA in 2009 (Kriaucionis and Heintz, 2009; Tahiliani et al., 2009) not only 
reawakened interest in a rare nucleotide, but also highlighted the shortcomings of previous 
methylation assays. In fact, enzymatic approaches and traditional bisulfite sequencing were 
shown to be unable to distinguish between 5meC and 5hmC in DNA (Nestor et al., 2010), thus 
illustrating the need for urgent technical advances such as new antibodies and oxidative bisulfite 
sequencing (Booth et al., 2012).  
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The TET proteins comprise a family of 2-oxoglutarate (α-ketoglutarate)- and Fe(II)-
dependent enzymes (Tahiliani et al., 2009). All three TET proteins contain a catalytic C-terminal 
CD domain (Cysteine-rich region and Double-stranded β-helix domain) (Tan and Shi, 2012). 
Both TET1 and TET2 regulate 5hmC production in mouse embryonic stem cells, and are 
induced concomitantly with 5hmC during fibroblast reprogramming into induced pluripotent 
stem cells (Ito et al., 2010; Koh et al., 2011). Disruption of TET activity was first found in 
myeloid tumorigenesis (Pastor et al., 2011).  Loss of 5hmC has recently been shown as an 
epigenetic hallmark of melanoma, where 5hmC and TET2 protein expression also negatively 
correlate with melanoma progression (Lian et al., 2012; Gambichler et al., 2013). In addition, 
5hmC levels are decreased across a broad range of other cancers, such as oral squamous cell 
carcinoma (Jäwert et al., 2013), brain tumors, and squamous cell lung cancers (Jin et al., 2011). 
In an elegant experiment to show that reduced 5hmC levels are the cause and not simply the 
consequence of carcinogenesis, injecting TET-depleted stem cells into mice led to aggressive 
and proliferative tumorigenesis, while injecting wild-type stem cells into mice only led to 
differentiated benign teratomas (Koh et al., 2011; Münzel et al., 2011).  
Although originally considered unlikely to be part of any active oxidative demethylation 
pathway due to previous inability to detect active demethylation intermediates(Globisch et al., 
2010), 5hmC now represents a pathway for DNA demethylation (Gong and Zhu, 2011), as it is 
repaired as mismatched DNA and replaced with normal cytosine. 5hmC can be further oxidized 
into 5-carboxylcytosine (5caC), another DNA demethylation intermediate with emerging 
evidence for diverse regulatory functions (Shen et al., 2013; Song et al., 2013; Song and He, 
2013). Since the maintenance of dynamic DNA methylation and demethylation processes seems 
crucial to mammalian development and pathogenesis, we strove to understand the impact of 
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epigenetic modifications on mutagenesis by exploring the roles of 5hmC and 5caC in modulating 
UV-induced DNA damage.  
 
Skin (Cells) as an Attractive System 
The skin provides an attractive system for studying normal cellular processes as well as 
cancer pathogenesis, since skin cells are abundant and easily accessible. Normal human skin is 
covered by a stratified epidermis that functions as a self-perpetuating barrier against harmful 
microbes, dehydration and other insults (Fuchs, 2008). This protection is maintained by a tightly 
regulated balance of cellular proliferation, differentiation and apoptosis within the skin cells 
(Gniadecki et al., 1997; Chaturvedi et al., 1999; Fuchs, 2008).  
The epidermis forms the top protective covering of normal skin, and is itself composed of 
multiple layers from the stratum corneum or horny layer at the top to proliferating cells in the 
basal layer that are anchored to the basement membrane. Keratinocytes constitute the majority of 
the epidermis, with some melanocytes to protect the deeper skin layers from harmful UV rays. 
The bottom layer of epidermal keratinocytes contains a single layer of basal, proliferative 
keratinocytes that give rise to daughter cells and progressively move outward and commit to 
terminally differentiate as they expand (Alonso and Fuchs, 2003; Fuchs, 2008). As 
differentiating keratinocytes move upwards into the spinous layer and then granular layer, and 
finally into the horny stratum corneum and exit at the skin surface (Alonso and Fuchs, 2003)—a 
process that takes approximately one month in human epidermis—their network of 10-nm 
keratin intermediate filaments strengthens to form IF cables that distribute force over an entire 
tissue by anchoring to desmosome junctions (Alonso and Fuchs, 2003). Once they have reached 
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the surface after major morphological changes, the differentiated keratinocytes have now become 
“enucleated cellular skeletons” that are continually sloughed at the surface and replaced by inner 
cells moving outward in a dynamic flux (Fuchs, 2008).   
The decreased incidence of skin cancers seen in individuals with darker skin may be 
attributed both to protective UV filtering and a more efficient removal of UV-damaged cells 
(Miyamura et al., 2007; Yamaguchi et al., 2006; Liu and Fisher, 2010). As a first line of defense, 
melanin pigments prevent UV-induced DNA damage upon sun exposure. Melanin is synthesized 
by melanocytes in the epidermis, and then distributed by neighboring keratinocytes into the 
upper skin layers. In addition to skin, melanin can also be found in hair, retina, iris and parts of 
the central nervous system (Yamaguchi and Hearing, 2009). 
Given their attractiveness as a model system and their direct relevance to studying UV 
damage, human and mouse skins, as well as the various primary cells (keratinocytes, 
melanocytes, fibroblasts) derived from them, have been popularly used as a supplement to 
immortalized cancer cell lines. Throughout the multiple projects I pursued during my graduate 
years, primary human keratinocytes and melanocytes were extensively used in conjunction with 
other systems to better mimic biological processes. In fact, observations in primary skin cultures 
often formed the basis for generating new hypotheses.      
 
Purpose and Hypothesis 
Originally, we were looking into a question related to, but slightly different from the focus of this 
thesis—whether UV irradiation has any effect on the methylation and demethylation of cytosine. 
Initial pilot immunofluorescence experiments suggested that in primary human skin cells (dark 
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as well as white primary melanocytes, primary keratinocytes, and primary fibroblasts), 5hmC 
expression was significantly enhanced within 3 hours of UV irradiation; we were encouraged by 
a lack of similar observation in cancer cells, since TET enzymes are mutated or downregulated in 
multiple cancers. Although loss-of-function mutations in TET genes have not been found in 
human solid tumors yet, mutations in TET genes were frequently found in hematological 
malignancies, and downregulation of TET expression was observed in human breast, liver, lung, 
pancreatic and prostate cancers (Wu and Ling, 2014). This correlates with reduced 5hmC levels 
in various tumors, as 5hmC reduction can result from loss-of-function mutations in TET genes 
and from inhibition of TET activity through reduced α-ketoglutarate (oxoglutarate) levels or 
increased 2-hydroxyglutarate levels (via IDH1/2 mutations) (Yang et al., 2013). Among the 
currently known mutations in TET genes, the MLL-TET1 (t(10;11)(q22;q23) translocation was 
identified in acute myeloid leukemia and acute lymphoblastic leukemia, while a deletion of 2p23 
was seen in myelodysplastic syndrome, and a range of nonsense/missense/frameshift mutations 
and deletions was found in the cysteine-rich region or catalytic domain of TET2 (Kinney and 
Pradhan, 2013). My preliminary analysis of TET mutations in skin cutaneous melanoma (Broad, 
Cell 2012; The Cancer Genome Atlas; Yale, Nature Genetics 2012; cBioPortal for Cancer 
Genomics) revealed a large number of C to T or CC to TT missense transition mutations in 
TET1/2/3 (see Chapter 3 for further discussion).  However, the lack of reliable DNA 
demethylation antibodies at the time (back in 2010), in addition to technical concerns about false 
positives from UV crosslinking, led us to hand over this project to multiple collaborators (whose 
recent mass spectrometry results seem to validate our original observations).  
Therefore, in moving forward, we modified our objectives: For this thesis, we are 
building upon current understanding of the effect of cytosine methylation on photoproduct 
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formation and mutagenesis, and extending our studies into the rapidly evolving field of 
hydroxymethylation and carboxylation. We hypothesize that 5-hydroxymethylcytosine and 5-
carboxylcytosine are part of a protective, TET-mediated DNA demethylation pathway for 5-
methylcytosine, and thus they will mitigate UV-induced photoproduct formation, in contrast to 
enhanced CPD formation by the 5-methyl moiety.   
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CHAPTER TWO 
 TETrify against UV: 5hmC and 5caC protect from UV-induction of CPDs 
 
Intrastand CPD dimers and their well-known UVB-signature mutations have been linked 
to basal cell carcinoma and squamous cell carcinoma (Brash et al., 1991), and there is a strong 
association between melanoma risk and UVB exposure (Fears et al., 2002). The most prevalent 
UVB-induced DNA lesion, CPDs are both abundant and mutagenic, and their repair is slow and 
inefficient. CPDs are premutagenic lesions for cytosine to thymine transitions, the UVB 
signature mutations (LeClerc et al., 1991; Otoshi et al., 2000). In human basal and squamous cell 
carcinomas, these mutations have been found especially in trinucleotide sequences containing 5-
methylcytosine (Tornaletti and Pfeifer, 1995; You and Pfeifer, 2001; Lee and Pfeifer, 2003; 
Cannistraro and Taylor, 2009). The C to T transition process at dipyrimidine sequences involves 
deamination of cytosine, and methylation at the C-5 carbon of cytosine both enhances 
dimerization and promotes deamination, leading to enhanced CPD formation and increased UVB 
signature mutations (Douki and Cadet, 1994; Tommasi et al., 1997; You et al., 1999; Douki et 
al., 2000; Mitchell, 2000; Cannistraro and Taylor, 2009; Rochette et al., 2009). The TET 
machinery can oxidize 5meC into 5hmC and 5caC (Gong and Zhu, 2011; Shen et al., 2013; Song 
et al., 2013; Song and He, 2013). 5hmC levels are reduced in melanomas, oral squamous cell 
carncioma, brain tumors and other cancers (Lian et al., 2012; Gambichler et al., 2013; Jäwert et 
al., 2013), correlating with TET mutations or downregulation in multiple cancers (Wu and Ling, 
2014). Since 5hmC and 5caC are part of a TET-mediated DNA demethylation pathway, and 
methylation has been associated with enhanced formation of premutagenic UVB lesions, we 
studied the effects of hydroxylation and carboxylation on UVB induction of CPD dimers.  
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Methodology 
Our approach to studying the effect of epigenetics on UV-induced CPD formation was to 
first choose an in vitro system to validate previous findings on 5meC (Douki and Cadet, 1994; 
Tommasi et al., 1997; You et al., 1999; Douki et al., 2000; Mitchell, 2000; Cannistraro and 
Taylor, 2009; Rochette et al., 2009). While DNA dot blots previously worked well for 
quantifying levels of 5meC and 5hmC, they could not be used for measuring CPD formation, as 
UVC crosslinking (which was requisite to bind samples to the dot blot membrane) distorted 
subsequent measurements of UVB-induced CPDs.  
Therefore, we optimized an ELISA assay from Cosmo Bio, Inc., for our in vitro tests on 
modified oligonucleotides. Compared to standard sandwich ELISAs, our protocol incorporates 
an additional biotin-conjugated antibody in order to enhance signal intensity. We first tested out 
our protocol on genomic (herring sperm and calf thymus) DNA as well as 18bp-oligonucleotides, 
both under single-stranded (heated) and double-stranded (non-heat-denatured) conditions, before 
proceeding to assay optimization with the desired 11bp-modified oligonucleotides (single-
stranded). Under optimized conditions [1:1000 anti-cylobutane pyrimidine  dimers monoclonal 
antibody (Cosmo Bio USA), followed by 1:2000 biotin-xx F(ab’)2 fragment of goat anti-mouse 
IgG (Life Technologies) and 1:5000 peroxidase-streptavidin  in order to enhance signal intensity 
detected at 490 nm with 8 mg/20mL O-phenylenediamine dihydrochloride (Sigma Aldrich) 
(stopped by 2M H2SO4)], we could show that 5meC enhances UV-induced CPD dimer 
formation, in agreement with previous literature as described above. 
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Since a flanking guanine base has been shown to enhance CPD formation and accelerate 
cytosine deamination through the oxidation potential of its O6 group (Cannistraro and Taylor, 
2009),	  we firstly chose a set of oligonucleotide sequences flanked by guanine, reasoning that 
differential responses to UVB-induced photodimer formation will be more distinguishable if we 
used a master sequence that promotes maximal induction. Our initial set of modified 
oligonucleotides comprises the following sequences: 5’-AAAAAAAACXG-3’ and 5’-
AAAAAAAATXG-3’, where X= C, 5meC, 5hmC, 5caC, T. For experiments with double-
stranded DNA, we designed oligonucleotides with a CpG dinucleotide in the middle (in order to 
avoid artificial outlier observations that might have resulted from a terminal cytosine): 5’-
ATATXGATATA-3’/5’-TATATXGATAT-3’, X=C, 5meC, 5hmC.   
In proceeding with experiments with genomic DNA extracted from TET overexpressing 
A2058 melanoma cells (either overexpressing full-length active TET2 (FL2) or mutant TET2 
(mut)) from the lab of our collaborator, Professor Yujiang Shi at BWH (Lian et al., 2012), we 
found that simply adapting our assays for cellular DNA does not always work. Cells were grown 
to confluencies ranging from 50-70%, irradiated with a UVB lamp at various doses, and 
harvested in lysis buffer at set time points. Genomic DNA was extracted by a phenol/chloroform 
protocol (during my rotation project, I had assessed the relationship between UV dose, cell 
confluency, and sensitivity to apoptosis in primary melanocytes and keratinocytes—while some 
of the cells we used to study the effects of epigenetic modifications on UV photoproducts are not 
primary, my earlier work revealed the optimal range of UV doses and DNA extraction protocols 
(coated spin columns versus gravity columns versus phenol/chloroform organic separations) to 
use in cells). We suspected that in vitro assays may respond to DNA of different lengths with 
bias, and so I first sonicated genomic samples (Bioruptor sonicator; Diagenode) for a range of 
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sonication durations, ran them on 2.5% agarose gels to check for even smear patterns, and 
selectively tested out in ELISA assays. The ELISA assays I had previously optimized for 
oligonucleotides worked best with briefly sonicated (5 min or 10 min) DNA that was heat-
denatured; however, this assay only worked with certain antibodies against photoproducts from a 
Japanese company (Cosmo Bio), but did not work with 5meC or 5hmC antibodies (even though 
those results were beautiful and extremely sensitive for our 11 bp oligos). Thus, I proceeded to 
test out other antibodies, as well as a 5hmC ELISA kit (Zymo Research Corporation) that was 
previously published (in testing unsonicated, genomic DNA across range of tissues); as it turns 
out, that kit did not work either, even their own controls barely fit on a standard curve, raising 
doubts about the accuracy of commercially available 5hmC kits. 
In order to compare and contrast the levels of 5hmC, 5meC and 5caC between cells with 
different TET expressions, I went back to dot blots. As explained above, the membrane 
crosslinking required for sensitive detection undermined quantification of photo-dimers, but does 
not hinder detection of epigenetic markers such as 5hmC. The dot blots had a preference for 
sonicated DNA (any sonication time seemed to work well), and heat denaturation did not seem to 
be necessary (unlike ELISA assays). Also, I found that for the 5meC (EMD Biosciences) and 
5hmC (ActiveMotif) antibodies selected, the dot blots worked better, and more consistently, on 
Hybond-N+ nylon (GE Healthcare Life Sciences)  membranes instead of nitrocellulose 
membranes (which a previous collaborator, A. Rao, had advised for their own 5hmC antibody).  
For broadspectrum UVB irradiations, we used two Stratagene UVB light bulbs at doses 
ranging from 100 mJ/cm2 to 4 J/cm2 (based on insights from previous unrelated side-projects on 
oligonucleotides, primary and cancer cell lines, skin explants, and mice). For UVA irradiations, 
we used two Stratagene blacklight bulbs at doses ranging from 1 J/cm2 to 40 J/cm2. UVB/UVA 
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emittance was measured with an ILT1400 photometer (International Light Technologies, Inc.) 
equipped with a UVB-1 SEL240 probe or UVA SEL033 probe, respectively. For UVC 
irradiations, we used two 15 W 254 nm germicidal bulbs (Stratagene) at timed doses (2-20 min). 
UVC doses were measured with a Thorlabs power meter (with a 250 nm filter) by recording and 
manually integrating a Watts versus time plot.  
 
Controls and Addressing Potential Pitfalls 
 In addition to testing commercial standards (Cell Biolabs, Inc.; Zymo Research 
Corporation) to validate our ELISA assays, we also designed our own positive and negative 
controls (custom modified oligonucleotides from Eurofins MWG Operon served as epigenetic 
standards; various cellular DNA verified by immunofluorescent staining, as well as calf thymus 
DNA under known conditions, served as standards for photoproducts). Since our 
oligonucleotides of interest were all 11 bp long, we used a representative sequence (oligo #6 = 
5’-AAAAAAAATCG-3’) to establish a standard curve (Figure 1). This revealed an optimal 
DNA concentration of 0.1188 µM (20 ng/50µl for oligo #6), which showed a fairly linear CPD 
dimer vs. UV dose response curve (Figure 2). We used these DNA concentrations throughout our 
ELISA assays on oligonucleotides and cellular DNA to ensure consistency (except in cases of 
high absorbance values, where we performed dilutions as necessary). Additional tests using 
mouse IgG (the Cosmo Bio antibodies against CPDs, 6-4 PPs and Dewar isomers were all 
monoclonal, mouse) were performed to test the quality of the antibodies. ELISA experiments 
using mouse IgG or with any missing subsequent antibodies did not show any UV induced 
increase in absorbance values, as expected.         
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Figure 1: Standard curve for CPD detection by ELISA (n= 3).  
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Figure 2: ssOligo6: CPD induction vs UVB dose (ELISA, n= 3). 
 We had several other concerns about using ELISA assays to measure the levels of 
photoproduct inductions. In case any reductions in CPD levels detected for 5hmC 
oligonucleotides were not due to the hydroxymethyl moiety but to instability upon irradiation, 
we decided to test the stability of the hydroxymethyl moiety. Our results do not suggest any 
hydroxymethyl instability upon broadspectrum UVB irradiation (Figure 3a). Similarly, the 5meC 
moiety did not display any instability upon UV irradiation (Figure 3b). Figure 3 (and other data, 
not included here) also shows that our oligonucleotides contain the correct modified bases as 
specified.      
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Figure 3a: 5hmC stability in oligonucleotides unaffected by UV irradiation/time/heat  
(ELISA, y-axis: 5hmC (absorbance), n= 3). 
 
 
 
Figure 3b: 5meC stability in oligonucleotides unaffected by UVB treatment  
(ELISA, y-axis: 5meC (absorbance), n= 3). 
 
 
 As another measure of quality control, we tested the levels of CPD dimers in our single-
stranded oligonucleotides both immediately after UV-treatment and after 24 hr (in a warm room, 
37ºC). For oligonucleotides that were significantly photodimerized with 1 J/cm2 broadspectrum 
UVB, we saw a 30-40% reduction in CPDs after 24 hr exposure to heat and light (Figure 4). This 
does not conflict with current knowledge that the dimerization of CPDs is reversible (Witkin, 
1975; Szekeres et al., 1976).   
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Figure 4: Reduction of UV-induced CPD dimers with time  
(ELISA, y-axis: CPD (absorbance), n= 3). 
 
 
Furthermore, we were concerned about the high background absorbance measured at both 
490nm and 450nm, despite diluting antibody concentrations. Since many instruments fail to 
follow the Beer-Lambert law (for linearity) at absorbance units above 2 (corresponding to light 
transmittance below 1%), it was important to bring down the background in order to obtain more 
meaningful signal: noise ratios. I found it necessary to individually optimize assay conditions for 
different sample groups (e.g., more dilute DNA concentrations for sequences containing a 
thymine) in order to be able to obtain meaningful (and comparable) observations. Switching 
from an HRP-based reading to a luminescence output did not improve our ELISA assays. 
However, we found that prolonging the blocking step cut down background signals in half, and 
reduced the variability in our samples as well (Figure 5).  
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Figure 5: Impact of block duration on signal detection (ELISA, y-axis: CPD (absorbance), n= 3).  
  
Results 
Our first aim was to test the hypothesis that a methyl moiety at the C-5 position enhances 
UV induction of CPD dimers. In ELISA tests with our first set of single-stranded 
oligonucleotides (detailed above), we observed trends consistent with those published in recent 
literature (Douki and Cadet, 1994; Tommasi et al., 1997; You et al., 1999; Douki et al., 2000; 
Mitchell, 2000; Cannistraro and Taylor, 2009; Rochette et al., 2009). More specifically, we 
observed up to 4-fold enhanced CPD induction (red versus orange bars, Figure 6) in the presence 
of a methylated cytosine (with 10-fold signal:noise ratios).  
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Figure 6: CPD induction by UVB in ACXG oligonucleotides  
(ELISA, y-axis: CPD (absorbance), n≥ 3, unpaired t tests). 
 
 
Our second aim was to establish whether a hydroxymethyl moiety would reduce or even 
protect from UV-induced CPD dimer formation. Since hydroxylation of 5meC by TETs initiates 
demethylation, we hypothesized that the hydroxymethyl moiety would have effects opposite to 
enhanced inductions seen with a 5-methyl moiety. As predicted, our results indicated that the 5-
hydroyxmethyl moiety on cytosine mitigates methylation-related CPD enhancement upon UV 
irradiation. Depending on sequence context, UV-induced formation of CPDs was up to 3-fold 
lower for 5hmC-containing oligonucleotides than their 5meC counterparts (Figure 7). 5hmC’s 
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protective effect on the UV response was also upheld in duplex oligonucleotides, although at a 
lower ratio but still with statistical significance (Figure 8).  
 
Figure 7a: Shielding from UV-induced formation of ATXG CPDs  
(ELISA, n= 9, multiple unpaired t tests). 
 
 
Figure 7b: Shielding from UV-induced formation of ACXG CPDs  
(ELISA, n≥ 5, multiple unpaired t tests). 
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Figure 8: UV induction of CPDs in duplex ATXGAT 
(ELISA, n≥ 5, unpaired t test). 
 
As we were validating our results in a cellular model, we decided to repeat and extend 
our studies to include 5-carboxylcytosine (initially omitted from oligo designs), another TET-
oxidized product of 5meC (downstream of 5hmC). As a DNA demethylation intermediate, we 
hypothesized that 5caC would also mitigate UV induction of CPDs. Similar to 5hmC, our results 
showed that CPD formation was up to 3-fold lower for 5caC-containing oligonucleotides than 
their 5meC counterparts (Figure 7). This protective effect was especially pronounced in the 
AC5caCG sequence context.  
Part of our interest in 5caC was sparked by the technical advances made by our 
collaborator, Prof. Y. Yang at UC Riverside, which enabled the quantification of TET-oxidized 
products of 5meC, including 5hmC and 5caC (Liu et al., 2013). Yet another reason was the 
recent publication of a paper on the formation of CPDs in 5hmC-containing dipyrimidines (Kim 
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et al., 2013). Their work on 5hmC CPD dimers validated some of our in vitro data, as their 
oligonucleotides shared sequence similarities with ours (we designed our study to detect 
maximum differences), and they used similar high UV doses similar as well. However, by 
postulating a protective role for 5hmC and 5caC in the UV induction of photoproducts, we 
sought to expand our work beyond an in vitro proof-of-existence story for 5hmC-containing 
CPD dimers. Technical limitations (difficulty of designing 5fC-containing oligonucleotides) led 
us to postpone extending our studies to 5-formylcytosine (5fC) as well, another novel DNA 
demethylation intermediate (between 5hmC and 5caC). 
As a third aim, we set out to validate our observations in a more biologically relevant 
system with a cell model from our epigenetics collaborator, Prof. Y. Shi at BWH. We used Prof. 
Shi’s previously established melanoma cell model that contains abundant 5meC but negligible 
5hmC levels (Lian et al., 2012). By DNA dotblot with antibodies against 5hmC and 5meC 
(Figure 9a), we saw that overexpression with a full-length active TET2 led to increased 5hmC 
levels. 5hmC measurements by ImageJ software from the NIH after background adjustments 
(automatic light background with rolling ball radius of 50.0 pixels) were as follows: At 1 µg 
DNA dilution, 29281.894 area for TET2+ versus 8485.430 area for TET2- cells (3.34:1), at 800 
ng DNA dilution, 30802.723 versus 6882.752 (4.48:1), at 400 ng DNA dilution, 34423.614 
versus 5856.095 (5.88:1), at 200 ng DNA dilution, 35924.555 versus 22472.782 (1.60:1); hence, 
at a non-saturated dilution of 400ng DNA, there was a maximum 5.88:1 or 1:0.17 5hmC ratio for 
TET2+:TET2- cells. 5meC measurements by ImageJ software from the NIH after background 
adjustments (automatic light background with rolling ball radius of 50.0 pixels) were as follows: 
at 1 µg DNA dilution, 7893.255 area for TET2+ versus 10949.255 area for TET2- cells (1:1.39); 
at 800 ng DNA dilution, 9057.497 versus 12467.376 (1:1.38); at 400 ng DNA dilution, 7670.255 
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versus 11471.255 (1:1.50); at 200 ng DNA dilution, 5899.134 versus 10936.134 (1:1.85); at 100 
ng DNA dilution, 7062.477 versus 10315.770 (1:1.46); at 50ng DNA dilution, 10047.134 versus 
10195.205 (1: 1.01). Given the strong saturation of 5meC dots at multiple DNA dilutions 
(indicating abundance of 5meC in cellular DNA) for both TET2+ and TET2- cells, as well as the 
arbitrary surface area estimations by ImageJ, the best estimate of 5meC ratios for these cells was 
an average of ratios from all serial dilutions, which was 1:1.43 or 0.70:1 for TET2+:TET2- cells.    
Previous studies have shown that both UV irradiation of intact cells and naked DNA 
produced similar distributions of CPD inductions, although the cellular environment decreased 
the apparent UV dose by 50% through shielding of the nuclear DNA (Lippke et al., 1981). 
Furthermore, recent mass spectrometry data has shown that natural 5hmC levels only reach a 
fraction of 5meC cellular levels (<15% in human brain, <10% in mouse brain, <20% in HEK 
cells, <5% in mouse skin (Liu et al., 2013)). Given the overshadowing abundance of 5meC 
relative to 5hmC in our cellular model, as well as the reduction in apparent UV dose through 
cellular shielding, the protective effect in TET2-overexpressing cells was statistically significant 
only at the highest UV dose. At 3J/cm2 of UVB (Figure 9b), induction of cyclobutane pyrimidine 
dimers was significantly lower (p<0.0003) in TET2 overexpressing cells (with higher levels of 
5hmC) than in TET2 mutant cells. These results are in agreement with the protective effect we 
observed in our oligonucleotide studies noted earlier. Taken together with novel evidence for 
loss of 5hmC as an epigenetic hallmark of melanoma (Lian et al., 2012; Gambichler et al., 
2013), our results suggest that 5hmC offers protection from UV-induced cyclobutane pyrimidine 
dimer formation, and thus TET oxidation of 5meC might be a cellular mechanism to protect 
against UV damage.  
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Figure 9a: 5hmC and 5meC levels in melanoma cells (DNA dotblot, serial dilutions). 
 
Figure 9b: CPD induction by UV in melanoma cells (ELISA, n≥ 5, unpaired t test). 
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From in vitro studies of UV irradiated plasmid DNA, we could assume 0.3 CPDs per 108 
daltons of DNA per 1 J/m2 of UVB irradiation, or 2.4 CPDs per 108 daltons of DNA per 1 J/m2 
of UVC irradiation (Mitchell et al., 1991). Using simple math assumptions (~650 dalton/bp), and 
the highest dose of UV that I used for both cells and oligo experiments (3J/cm2 for UVB, 3.2 
J/m2 for UVC)--this comes to 58,500 CPD/million bp under UVB or 499,200 CPD/million bp 
under UVC. From the previous discussion of induction ratios (see Chapter 1), the ratio of TT: CT 
+ TC: CC CPDs after UVB irradiation range from 40:40:20 to 52:40:7 (Mitchell et al., 1991). 
Therefore, of the 58,500 CPD/million bp, about 40% or 23,400 CPD/million bp would contain a 
cytosine. This would translate into 70.2 million cytosine-containing CPDs across a human 
genome with 3 billion base pairs.  
We saw that UV-induced formation of CPDs was up to 3-fold lower (70% reduction) for 
5hmC-containing oligonucleotides than their 5meC counterparts (Figure 7). With about 3% of all 
cytosines methylated in human DNA, and a maximum of 5% of all 5meC hydroxylated in skin 
(Liu et al., 2013), even a 70% shielding would only lead to a 3.5% overall protection for a rare 
5hmC subpopulation. This could translate into 2.5 million fewer CPDs per cell (3.5% of 70.2M) 
under the UVB doses that I used. The protective shielding by 5hmC against UVB-induced CPDs 
is probably most influential through context dependence: Just as we observed a sequence 
dependence for the extent of 5hmC’s shielding (Figures 7, 8), it is plausible that 5hmC may have 
a bigger impact in certain regulatory and tumor suppressor genes. For example, a large 
proportion of invasive SCCs contain UVB signature mutations in the p53 gene (Brash et al., 
1991), and over a third of these p53 mutations contain 5meC trinucleotides (Tornaletti and 
Pfeifer, 1995; You and Pfeifer, 2001; Lee and Pfeifer, 2003; Cannistraro and Taylor, 2009), even 
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though only a small fraction of all cytosines is methylated across the human genome. Since the 
loss of 5hmC has been associated with numerous cancers, including melanoma (Lian et al., 
2012; Gambichler et al., 2013), perhaps the protective effect from a rare 5hmC in a cell is 
enhanced through sequence context and its location in a pivotal gene like p53. Furthermore, it 
has been previously shown that the frequency of CPD formation oscillates along the DNA 
backbone, with maximum induction near sites farthest from the surface of core histones, and 
minimum induction near sites closest to the surface of core histones (Gale et al., 1987). If the 
genome were preferentially hydroxylated at sites farthest away from histone surfaces, the 
protective effect from a rare yet potent 5hmC could significantly reduce the formation of 
premutagenic CPD lesions.  
 
Contributions: Prof. Geno Y. Shi (Brigham/Women’s Hospital, Harvard) provided frozen vials 
of both TET2+ and TET2- cells, while I performed all sample preparations and biochemical 
assays (ELISAs, dot blots, UV treatments).  
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CHAPTER THREE 
To protect or not to protect: 5hmC’s dual roles in modulating photoproduct formation 
 
In addition to CPDs, another type of intrastrand DNA lesion is (6-4) photoproducts (6-4 
PPs). Depending on the chemical nature of the two pyrimidine bases involved and other 
parameters, both the yield and the ratio between CPDs and 6-4 PPs upon UV irradiation can vary 
greatly (Douki, 2006). Like CPDs, 6-4 PPs are premutagenic lesions for cytosine to thymine 
transitions; however, 6-4 PPs are also premutagenic lesions for thymine to cytosine transitions 
(LeClerc et al., 1991; Otoshi et al., 2000). We extended our in vitro studies into 6-4 PPs by using 
the same ELISA and dotblot assays as above; therefore, the methodology and controls were 
similar to those in Chapter 2.  
 
Results 
Further experiments investigating how DNA demethylation intermediates modulate UV 
formation of photoproducts have revealed an interesting duality for 5-hmC. Both single-stranded 
(Figure 10a) and double-stranded (Figure 10b) 5hmC-containing oligonucleotides, as well as 
genomic DNA extracted from UV-irradiated TET2-overexpressing cells, showed statistically 
significantly enhanced UV induction of (6-4) photoproducts (Figure 10c). In oligonucleotides, 
methylation at the C-5 position did not alter UV induction of 6-4 PPs, while carboxylation at the 
C-5 carbon hindered 6-4 PP formation, which is in line with our hypothesis and earlier results 
showing 5caC’s protective shielding from UV induction of CPDs.  
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Figure 10a: 5hmC enhances UVC-induced formation of 6-4 PPs  
(ELISA, n≥ 3, multiple unpaired t tests). 
 
 
Figure 10b: UV induction of 6-4 PPs in duplex ATXGAT (ELISA, n= 3, unpaired t test). 
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Figure 10c (Continued): 6-4 PP induction by UVC in melanoma cells  
(ELISA, n≥ 3, unpaired t test). 
 
Contrary to our expectations, the presence of 5hmC increased UV inductions of 6-4 PPs 
by 30% or more (Figure 10).  UVC (Figure 10a) was a more potent inducer of 6-4 PPs than 
(broadspectrum) UVB (Figure 11a), while UVA failed to induce any detectable levels of 6-4 
PPs. In cells, TET2 overexpression failed to enhance 6-4 PP formation under UVB (Figure 11c), 
but did with statistical significance under a high UVC dose (Figure 10c). Furthermore, 
hydroxylation-mediated 6-4 PP enhancement was pronounced for ATXG sequences (Figure 
11a), but absent for ACXG sequences (Figure 11b). This is consistent with current knowledge 
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that 6-4 PPs are formed at 5’-TC-3’, 5’-CC-3’, and 5’-TT-3’, but not at 5’-CT-3’ sites in DNA 
(Häder and Sinha, 2005).  
 
Figure 11a: 6-4 PP induction by UVB in ATXG oligonucleotides  
(ELISA, n≥ 3, unpaired t test). 
 
 
Figure 11b: 6-4 PP induction by UVB in ACXG oligonucleotides  
(ELISA, n≥ 3, unpaired t test: p>0.05). 
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Figure 11c (Continued): 6-4 PP induction by UVB in melanoma cells  
(ELISA, n≥ 3, unpaired t test: p>0.05). 
  
For additional validation of 5hmC’s apparent enhancement of 6-4 PPs, we irradiated 
TET1/2 double-knockout (DKO) embryonic stem cells (from Y. Shi’s lab, Brigham/ Women’s 
Hospital, Harvard). Wild type (WT) embryonic stem cells had high levels of 5hmC, while 
TET1/2 DKO embryonic stem cells had low levels of 5hmC, as expected (Figure 12a). By DNA 
dotblot with antibodies against 5hmC, 5hmC measurements by ImageJ software from the NIH 
after background adjustments (automatic light background with rolling ball radius of 50.0 pixels) 
were as follows: At 1 µg DNA dilution, 74123.597 area for WT versus 1170.991 area for DKO 
cells (63.3:1), at 800 ng DNA dilution, 69681.342 versus 1471.527 (47.4:1), at 400 ng DNA 
dilution, 60932.907 versus 210.192 (289.9:1), at 200 ng DNA dilution, 52798.333 versus 
3011.962 (17.5:1); at 100 ng DNA dilution, 49106.312 versus 5848.421 (8.4:1); hence, at a non-
saturated dilution of 200ng DNA, there was a maximum 17.5:1 or 1:0.06 5hmC ratio for TET1/2 
WT:DKO cells. After UVC irradiation, the 5hmC-containing WT embryonic stem cells 
36	  
	  
enhanced induction of 6-4 PPs (p-value < 0.0001), in contrast to 5hmC-depleted TET1/2 DKO 
embryonic stem cells (Figure 12b). These results agreed with earlier results from melanoma 
cells, where TET2 overexpression (and correspondingly high 5hmC levels) led to enhanced UVC 
induction of 6-4 PPs (Figure 10c). While low-5hmC TET2- melanoma cells showed moderate 
UVC induction of 6-4 PPs (Figure 10c), UVC irradiation of low-5hmC TET1/2 DKO embryonic 
stem cells did not lead to significant 6-4 PP formation. This difference could potentially be 
explained by the significantly lower 5hmC ratio in the embryonic stem cells (1:0.06 for TET1/2 
WT:DKO) than in the melanoma cells (1:0.17 5hmC ratio for TET2+:TET2-), if 5hmC functions 
to enhance UV induction of 6-4 PPs. Therefore, our loss-of-function experiments with TET1/2 
DKO embryonic stem cells complemented our gain-of-function experiments with TET2 
overexpressing melanoma cells. 
 
Figure 12a: 5hmC levels in embryonic stem cells (DNA dotblot, serial dilutions). 
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Figure 12b (Continued): 6-4 PP induction by UV in TET1/2 DKO embryonic stem cells  
(ELISA, n≥ 4, unpaired t test). 
 
To explain the discrepancy between our hypothesis and 5hmC’s apparent dual effects on 
UV induction of photoproducts, we turned to structural modeling. Structures were generated 
visualized using UCSF Chimera (Pettersen et al., 2004). We used the structure of a T-T 
photoproduct from the Protein Data Bank (PDB ID: 1CFL) (Lee et al., 1999).  Assuming similar 
structural distortions in DNA for T-T and T-C 6-4 photoproducts (Kim and Choi, 1995), we 
converted the structure to a T-C photoproduct in an ATCG context using the swapna and Build 
Structure commands. We followed the structural description given by Douki (Douki, 2006). 
Modifications on the 5-position of the cytosine were incorporated using the Build Structure 
38	  
	  
command, and structures were then minimized using the Minimize Structure command. 
Following this, the Find Clashes/Contacts command was used to find pseudobonds.  
Structural modeling and Chimera visualization identified an additional potential 
hydrogen bond for the T-5hmC (6-4) photoproduct (Figure 13), suggesting a lower energy 
transition state for 5hmC.  Just as 5meC promotes the dimerization reaction with an adjacent 3’- 
cytosine (see discussion above in Chapter 1, introduction), leading to enhanced UV induction of 
CPD formation, a more favored transition state for the T-5hmC (6-4) photoproduct could explain 
5hmC’s duality in modulating the UV response. In addition to a lower energy transition state, the 
hydroxyl group may stabilize a T-5hmC radical, or promote DNA bending that would be 
favorable to forming a (6-4) adduct, as NMR spectroscopy data and structural calculations (Kim 
and Choi, 1995) suggested a 44 degrees distortion in the overall DNA helix. Yet a more bulky 
carboxyl group may counter any favorable energy stabilization and prevent (6-4) photoproduct 
formation through steric hindrance. Future structural studies such as free energy calculations are 
needed to further elucidate the rationale behind 5caC-containing oligonucleotides’ shielding 
effects (other than the absence of a dimerization-promoting 5-methyl group). The correlation 
between the presence of the hydroxymethyl moiety and (6-4) photoproduct formation is 
consistent with our model (see Chapter 4) of 5hmC as a selective epigenetic shield against UV 
damage, diminishing cyclobutane pyrimidine dimer formation while enhancing UV induction of 
(6-4) photoproducts.  
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Figure 13: Structural models of T-C photoproducts (with M. Stefan, HMS) 
Upper panel: Front view, lower panel: side view.  
The pseudobond identified by Chimera for T-5hmC is shown in orange. 
 
 
We found no significant induction of Dewar isomers in any of our oligonucleotides or 
genomic DNA under UVA or UVB irradiation (Figure 14). Dewar isomers are much more 
unstable than 6-4 PPs (Kan et al., 1992). Current literature suggests Dewar isomers of 6-4PPs 
mainly to be a UVC event and a two-step process. First, in synthetic processes, short oligomers 
(usually containing a thymine-thymine sequence) are irradiated under UVC (254nm), whereupon 
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TT 6-4 PPs are purified by HPLC. Next, these purified intermediates are irradiated under 320nm 
(UVA) to produce Dewar valence isomers (Yamamoto et al., 2006).  
 
Figure 14: Comparison of Dewar valence isomers after UVB irradiation  
(ELISA, y-axis: Dewar (absorbance), n≥ 4). 
 
Contributions: Prof. Geno Y. Shi (Brigham/Women’s Hospital, Harvard) and his postdoctoral 
fellow, Christian Argueta, provided TET2+/ TET2- melanoma and TET1/2 DKO ES cell. I 
performed all sample preparations and biochemical assays (ELISAs, dot blots, UV treatments), 
as well as bioinformatical analyses. Structural modeling using Chimera (UCSF) was done 
together with Melanie Stefan (Harvard Medical School). Mass spectrometry was done by S. Liu 
and Prof. Y. Wang (UC Riverside). 
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CHAPTER FOUR: DISCUSSION 
 
Highlights 
• 5hmC and 5caC protect from UV-induced formation of cyclobutane pyrimidine dimers 
• 5hmC also enhances UV-induced formation of (6-4) photoproducts  
• 5hmC’s duality upon UV damage is coupled to TET2 (over)expression 
 
 We have shown that 5meC enhances UV induction of CPDs in accordance with 
published literature (Douki and Cadet, 1994; Tommasi et al., 1997; You et al., 1999; Douki et 
al., 2000; Mitchell, 2000; Cannistraro and Taylor, 2009; Rochette et al., 2009). Furthermore, in a 
new model (Figure 15), we have shown via both modified oligonucleotides and melanoma cells 
that hydroxylation and carboxylation of 5meC by TET2 shield from CPD dimer induction. In 
addition, we point out a completely novel, contradictory role for 5hmC—enhancement of UV-
induced (6-4) photoproduct formation, potentially through a more favorable T-5hmC 6-4 PP 
transition state.  
 
Figure 15: Model. 
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We started with in vitro experiments measuring UV induction of photoproducts in 
various modified oligonucleotides. Given that a flanking guanine base enhances CPD formation 
and accelerates cytosine deamination (Cannistraro and Taylor, 2009), we firstly focused on a set 
of oligonucleotide sequences flanked by guanine, reasoning that differential responses to UV-
induced photodimer formation will be more distinguishable if we used a master sequence that 
promotes maximal induction. We optimized a biotin-enhanced ELISA assay in which 5-
methylation of a single cytosine in the oligonucleotides enhanced UV-induced CPD formation 
for both ATXG and ACXG sequences, in accordance with previously published in vitro studies. 
Our ELISA results also indicated that both the 5-hydroxymethyl and 5-carboxl moieties diminish 
methylation-enhanced CPD formation upon UV irradiation. Since both 5hmC and 5caC are TET-
mediated DNA demethylation intermediates, it is not surprising that they would have the 
opposite effect of the methyl moiety by reducing methylation-related CPD enhancement.   
Our observation of diminished UV induction of CPDs in DNA demethylation 
intermediates was also upheld in duplex oligonucleotides, as well as melanoma cells. We used a 
TET2 overexpression cell model designed by our collaborator Prof. Y. Shi. In addition, new 
experiments (by Y. Shi’s lab) with TET1/2 double-knockout embryonic stem cells (low 5hmC 
levels) showed a 2-4 fold increase in CPDs by immunofluorescent staining when compared to 
wild-type embryonic stem cells. While these loss-of-function results are still preliminary, they 
complement our gain-of-function results with TET2 overexpressing cells. Since the loss of 5-
hydroxymethylcytosine and inactivation of the TET enzymes have been implicated in skin 
cancers, and repeated exposure to UV radiation is a known risk factor for developing skin 
cancers, our data suggest a link between DNA demethylation and UV damage.  
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Further experiments on UV induction of Dewar isomers and 6-4 PPs revealed a lack of 
significant Dewar isomer formation under UVA/UVB, but significantly enhanced UVB/UVC 
induction of T-5hmC 6-4PPs. We attributed this to the different mutagenic properties of (6-4) 
photoproducts (capable of both C to T and T to C transition mutations). Structural modeling and 
Chimera visualization revealed an extra hydrogen bond between an amine group of thymine and 
a hydroxyl group on the adjacent cytosine, indicating a lower transition state for T-5hmC 6-4 
PPs. Our data suggest that upon UV damage, 5hmC may drive DNA lesion formation toward (6-
4) photoproducts, leading to diminished CPD induction and enhanced 6-4 PP induction. 
Depending on the chemical nature of the two pyrimidine bases involved, the wavelength 
of the incident photons, the stability of the duplex DNA, the ionic strength, and other parameters, 
the yield and the ratio between CPDs and 6-4 PPs inductions can vary greatly (Douki, 2006). 
Furthermore, the frequency of photoproduct formation oscillates along the DNA backbone with 
an average periodicity that is similar to the average repeat for the DNA helix (Gale et al., 1987). 
Since photoproduct formation requires local bending of the DNA helix, the frequency of 
photoproduct formation is reduced at sites closest to the surface of core histones, as histone 
binding to DNA would physically restrain movement in the DNA backbone (Gale et al., 1987). 
Compared to CPDs, this oscillatory dependence should be more limiting for the induction of 6-4 
PPs, which require a more severe distortion of up to 44 degrees in the DNA (Kim and Choi, 
1995). If there is a similar distribution pattern for hydroxylation/ demethylation along the DNA 
helix, the modulatory effects of a rare 5hmC on UV-induced photoproduct formations would be 
quite significant. In fact, while the presence of premutagenic photoproducts is required for 
mutations, mutation hot spots in human cells are determined by DNA structural features instead 
of photoproduct frequencies (Brash et al., 1987).   
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In shuttle vector mutation studies, UVB irradiation produced more mutations 
(insertions/deletions/transition mutations) than UVC irradiation; this also correlated with 
increased formation of cytosine containing CPDs under UVB (Keyse et al., 1988). While both 
CPDs and 6-4 PPs are premutagenic lesions for cytosine to thymine transition mutations, CPDs 
are responsible for the majority of UVB signature mutations in mammalian cells (Brash et al., 
1987; LeClerc et al., 1991; Otoshi et al., 2000). In fact, in repair-deficient xeroderma 
pigmentosum group A cells, CPDs were responsible for generating 90% of transition mutations 
(Brash et al., 1987). Additionally, 6-4 PPs are excised at double the rate of excision for CPDs in 
human, hamster and mouse cells (Mitchell et al., 1985; Mitchell et al., 1992). This more efficient 
removal of 6-4 PPs is also a very fast process, as over 70% of 6-4 PPs are removed within 4-6 hr 
after irradiation, compared to 17 hr for CPDs  (Mitchell et al., 1985). 6-4 PPs’ lower mutagenic 
potential and faster removal make them less toxic to cells than CPD lesions. Therefore, our 
observations that 5hmC drives UV induction of photoproducts toward 6-4 PPs and away from 
the more mutagenic CPDs is in alignment with our model of UV damage protection through 
hydroxylation and DNA demethylation.         
As new interest develops in the (rediscovered) DNA demethylation intermediates, 
evidence emerges for their diverse regulatory functions, ranging from developmental 
reprogramming to recruiting chromatin-altering binding proteins (Shen et al., 2013; Song et al., 
2013; Song and He, 2013). Our findings assign a new function to 5hmC and 5caC—as selective 
epigenetic shields against UV damage, contributing to the dynamic network of DNA methylation 
and demethylation that regulates mammalian pathogenesis.  
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Future Pursuits 
 More thorough studies can be carried out through a comprehensive set of sequence 
variations (flanking base, placement of moiety, length of oligonucleotide). In addition, we can 
complement (and validate) our TET overexpression gain-of-function data with TET- and 
DNMT-knockout loss-of-function cell models.  
Another goal we can pursue is to link CPD formation to methylation sites via a modified 
co-IP-ELISA on genomic DNA. This is a technically challenging feat, but the principle is 
straightforward: Since we are postulating that hydroxylation protects cytosines from 
methylation-enhanced, UVB-induced damage, we expect to see more CPD dimers formed at 
5meC than 5hmC post-UVB. We are planning to essentially separate 5meC and 5hmC 
populations from irradiated, TET2+ genomic DNA (by co-IP, both sequences will be tested and 
reversed as control), and then assaying for CPD levels by our ELISA protocol. An alternative 
might have been ChIPSeq, except that the bioinformatics world does not seem to think current 
5hmC or 5meC antibodies reliable enough for ChIPSequencing (based on discussions with Prof. 
Jun Song at UCSF), but we will not be attempting to reinvent any technical wheels. We could 
build on previous knowledge acquired during my year-long training with our previous mass spec 
collaborator (R. Giese, on interstrand adducts project, see Appendix), where a sequence of dual 
digestions with NP1 and PDE was used to cleave genomic DNA down to single nucleotides (as 
verified on HPLC). From here on, we will proceed with co-IP assisted by agarose beads, and 
ultimately followed by CPD ELISA as optimized before. A similar experiment could be 
performed to link 6-4 PP formation to hydroxymethyl sites on genomic DNA.     
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Yet another question we can address is whether modulation of photoproduct formation by 
5hmC and 5caC lead to reduced/ increased mutations. CPD-mediated C to T transition 
(especially in the p53 tumor suppressor gene) is the UV signature mutation for non-melanoma 
skin cancers. We expect that an analysis of the p53 mutation spectra (from the International 
Agency for Research on Cancer TP53 Database) to reveal the majority of UV mutations within 
methylated cytosine sequences. We expect that the correlation between mutation frequency and 
sequence specificity to agree with the trends we observe from our oligonucleotide studies. 
 Furthermore, our collaborator Prof. Y. Shi has shown that loss of 5hmC is an epigenetic 
hallmark of melanoma, as well as an indicator for melanoma progression (Lian et al., 2012). 
Injection of TET-depleted stem cells into mice led to aggressive and proliferative tumorigenesis, 
while injection of wild-type stem cells into mice only led to differentiated benign teratomas (Koh 
et al., 2011; Münzel et al., 2011). A preliminary analysis of TET mutations in TCGA skin 
cutaneous melanoma (cBioPortal for Cancer Genomics) revealed that C to T or CC to TT 
transitions accounted for a majority of their TET1/2/3 mutations (Figure 16), including one 
highly mutagenic nonsense mutation in TET1 (Figure 16a).   
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Figure 16a: TET1 mutations in skin cutaneous melanoma  
(TCGA, cBioPortal for Cancer Genomics). 
 
Figure 16b: TET2 mutations in skin cutaneous melanoma  
(TCGA, cBioPortal for Cancer Genomics). 
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Figure 16c (Continued): TET3 mutations in skin cutaneous melanoma  
(TCGA, cBioPortal for Cancer Genomics). 
 
More recently, as we have become interested in re-addressing our original question--
whether UVB affects TET activity, we have begun looking at precisely quantifying 5hmC and 
downstream products (such as 5fC, 5caC), both as a function of TET2 overexpression and with 
time after irradiation. This is something that we have asked our mass spectrometry collaborators 
at UC Irvine (Prof. Y. Wang) to look at, as they recently published about their own neat 
standards for mass spectrometry quantification of 5hmC, 5fC, 5caC and other epigenetic markers 
(Liu et al., 2013).	  One straightforward rationale for this study is that 5fC and 5caC are very 
newly discovered and barely examined epigenetic modifications, so any data we obtain would 
contribute to our understanding of the TET (specifically TET2) machinery. More importantly, 
we have another more ambitious interest in the UVB-DNA-TET2 interplay: The dynamic 5meC-
5hmC seesaw (Figure 17a). Our interest has stemmed from our own previously inconclusive 
histology observations that UVB irradiation may alter 5hmC levels in primary cells (which 
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express high levels of 5hmC, similarly to our TET2 overexpressing cells). We only observed this 
phenomenon in a time course setting, which would support the notion that this was dependent on 
a cellular machinery, such as the TET pathway. Therefore our mass spectrometry study is being 
carried with respect to time post UVB treatment as well. As expected, TET2 overexpression 
alone dramatically increased 5hmC levels in melanoma cells by almost 9-fold (Figure 17b), in 
line with earlier dotblot (Figure 9a, Chapter 2) and other results (Lian et al., 2012). Preliminary 
mass spectrometry results from S. Liu (Y. Wang’s lab) indicate a 40% increase in genomic 
5hmC levels (Figure 17b) in TET2 overexpressing melanoma cells within 24 hours of 
(broadspectrum) UVB treatment, accompanied by a 4% decrease in genomic 5meC levels 
(Figure 17c). If the relationship between 5hmC and 5meC were purely linear, we would expect 
only a 0.4% corresponding decrease in 5meC levels after 24 hours (initial, irradiated TET2+ cells 
with 0.0000559 5hmC/nucleoside and 0.023 5meC/dG = 0.00575 5meC/nucleoside corresponds 
to a 1 5hmC: 100 5meC ratio). We have sent more specimens to the mass spectrometry facility of 
our epigenetics collaborator Prof. Y. Shi, who picked up sample processing after our other 
collaborators decided to pursue other projects.  
 
Figure 17a: The (hypothetical) dynamic 5meC-5hmC seesaw. 
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Figure 17b (Continued): 5hmC measurements in melanoma cells by mass spectrometry  
(technical duplicates, S. Liu and Y. Wang, UC Riverside). 
 
 
Figure 17c (Continued): 5meC measurements in melanoma cells by mass spectrometry  
(technical duplicates, S. Liu and Y. Wang, UC Riverside). 
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APPENDIX 
 
Throughout my graduate research years, I worked on numerous projects that ultimately 
failed either due to technical limitations or ambiguous results. Two of them are worth 
mentioning here due to the interesting scientific questions that we posed.  
 
Past Project #1 (Major Concern: UV crosslinking distorted histology data.)  
(This project received NDSEG funding.) 
EXECUTIVE SUMMARY 
Because epithelial stem cells are thought to be the most likely targets of skin cancer 
initiation and tumor promotion (Morris, 2004), understanding the responses of the stratified 
epidermis to UV radiation, especially the effects of UVB on keratinocyte stem cells, has 
important implications for characterizing and utilizing skin stem cells, as well as for 
understanding and treating non-melanoma skin cancers.   
RATIONALE 
The normal cellular balance of life and death is regulated molecularly by the apoptosis 
machinery. Since UV radiation is a well-known trigger of the apoptotic cascade, there is 
considerable interest in understanding the apoptotic response of keratinocytes to UV-light. 
Current literature presents conflicting data on the UV-response of keratinocytes from different 
layers of the epidermis. I planned to characterize UV-induced apoptosis in keratinocytes, by first 
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identifying whether proliferative ability or differentiation status determines degree of 
sensitization or protection from UV-induced apoptosis. Subsequently, I investigated the 
mechanisms of this differential response to UV-light by examining the regulation of apoptosis 
machinery in keratinocytes. Furthermore, skin also exhibits robust regenerative capacity upon 
sun exposure, suggesting a subpopulation of cells with possibly stem-cell characteristics. Thus, I 
was also interested in isolating putative keratinocyte stem cells (KSC) from human skin in order 
to test if KSC’s are resistant to UV induced apoptosis as a protective mechanism in normal skin. 
Finally, I planned to inject UV-treated keratinocytes of various subpopulations into 
immunocompromised mice as an in vivo model to explore long-term effects of UV irradiation on 
keratinocytes and as an extension to studying tumorigenesis of keratinocytes.  
PRELIMINARY DATA 
It is unclear which subpopulation(s) of human keratinocytes become apoptotic in 
response to UV radiation, since current literature presents conflicting data (Gniadecki et al., 
1997; Chaturvedi et al., 1999; Tron et al., 1998; Tron et al., 1999). As a pilot study (see Figure 
A1), I used flow-cytometry-based propidium iodide/ annexin V staining of live cells to measure 
the apoptotic response 24hr after UV-irradiating (0, 20, or 40 mJ/cm2) human foreskin 
keratinocytes. I repeated these experiments on human foreskin keratinocytes that were previously 
induced to differentiate via 72-hr incubation in high-calcium medium (1.2mM Ca++). I also 
repeated the above experiments for the 48hr post-UV time point.  
Preliminary flow cytometry data (see Figure A1) suggested that the basal, proliferating 
keratinocytes, which consist of mostly transiently amplifying (TA) cells, to be sensitive to UV-
induced apoptosis, because higher fractions of Annexin V and PI-positive cells were observed by 
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flow cytometry when human foreskin keratinocytes were UV-treated for 24hr compared to non-
UV-treated controls (left panel, Figure A1). For calcium-treated differentiating keratinocytes, the 
percentage of apoptotic cells remained constant across all doses of UV treatment and was 
comparable to control cells (right panel, Figure A1), suggesting that differentiated keratinocytes 
are resistant to UV-induced apoptosis. Controls (no dye or fluorescein-conjugated marker) 
confirm minimal background signals (top row, Figure A1). But the extent of differentiation was 
not measured in these in vitro assays, and thus further experiments were needed to validate the 
preliminary data.  
 
Figure A1: Annexin V/ PI live exclusion assay (FACS). 
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Furthermore, preliminary histology data suggested that a fraction of basal keratinocytes 
(possibly keratinocyte stem cells, KSCs) were protected from UV-induced apoptosis as well. 
Fresh human neonatal foreskin was UVB-irradiated at 250 mJ/cm2, collected and processed after 
5 hours, paraffin-embedded and stained for apoptosis via a fluorescent TUNEL assay (Figure 
A2). DAPI-counterstained nuclei (bottom row, Figure A2) highlight the layers of keratinocytes 
in human epidermis. While most keratinocytes in the UV-treated epidermis (and even dermis) 
labeled both DAPI- and TUNEL-positive (bright FITC signals, top row, Figure A2) to indicate 
abundant DNA fragmentation, some basal-layer keratinocytes only labeled DAPI-positive, 
suggesting that a fraction of basal keratinocytes may be resistant to UVB-induced apoptosis. 
Because keratinocyte stem cells probably reside in the epidermal basal layer of non-follicular 
skin (So et al., 2004; Fuchs et al., 2008), it is possible that, given the general resilience of stem 
cells, the UV-resistant basal keratinocytes correspond to a keratinocyte subpopulation with stem-
like characteristics.       
Fig. 4: Preliminary Histology Data: TUNEL
UV 250mJ/cm2x 5h No UV
FITC
DAPI
 
Figure A2: TUNEL staining. 
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Past Project #2 (Major Concern: Disagreement with collaborators on structure determination.) 
(This project received F31 NRSA funding from the NIH.) 
EXECUTIVE SUMMARY 
Through studies on mouse skins and short oligonucleotides, we potentially discovered novel 
interstrand DNA adducts from UV radiation. UV radiation is known to cause DNA strand breaks 
and lesions. However, the UVB-signature CPD lesion is intrastrand, and in vitro interstrand 
experiments have used secondary crosslinking reagents such as mitomycin C. Our discovery of a 
novel cytosine interstrand (<CC>) adduct can be contributed to our unique Mass Tag Profiling 
methodology. Given the complexity (rigidity) of our hypothesized structure and the usually 
highly genotoxic nature of interstrand lesions, we investigated the impacts of our interstrand 
adducts on DNA damage and repair through in vitro repair-deficient cell models and in vivo skin 
samples, in addition to additional mass-spectrometry-based characterization studies.  
RATIONALE 
UV radiation from sunlight increases the risk of developing skin cancers, including 
malignant melanoma arising from the pigment-producing melanocytes in skin. However, the 
precise role of UV-induced DNA damage and repair in melanoma pathogenesis remains 
controversial. Many common melanoma mutations (such as BRAF somatic missense mutations) 
do not correspond to known UV signature mutations, and UV-signature CPD dimers and 6,4-
photoproducts are absent in most melanomas (Kao et al., 2011).  
Melanoma is the most dangerous type of skin cancer. With about 48,000 melanoma-
related deaths reported worldwide every year, it is the leading cause of death from skin disease. 
However, while repeated exposure to UV radiation from sunlight is known to increase the risks 
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of developing all skin cancers by mutating the cellular DNA, currently known UVB-signature 
mutations from intrastrand pyrimidine dimers (CPD dimers) only account for the less deadly, 
non-melanoma skin cancers (BCC, SCC). The goal of this project was to identify and 
characterize novel UV-induced DNA lesions that may serve as new signature mutations for 
melanoma, in the hope that we may suggest new diagnostic tools for life-saving early detection 
and that new insights on melanoma pathogenesis may lead to more effective therapeutic 
interventions.  
When UV radiation damages a cell, it mutates the cellular DNA with distinctive 
mutational patterns. Currently, the major known UVB lesions are pyrimidine dimers (Gale et al., 
Proc Natl Acad Sci U S A 1987), resulting in a four membered ring from covalent linkages of the 
carbon–carbon double bonds on adjacent pyrimidines. These cyclobutane-type pyrimidine 
dimers (CPDs) are quite mutagenic, especially in mammalian cells, initiating primary base 
substitutions in DNA. UVB induces cytosine to thymine transitions at the dipyrimidine sites, 
creating a UV-specific mutation signature that is ubiquitously observed in multiple organisms. 
UVB radiation produces most of the CPD photoproducts in mammalian skin compared to UVA, 
which comprises most sunlight radiation at the earth’s surface; UVC is even more potent, but it 
is thought to be significantly screened out via the ozone layer. 
However, CPD dimers are intrastrand lesions, much less toxic than their interstrand 
crosslinked counterparts. Among the early-known and widely-used chemotherapeutic agents, 
many such as cyclophosphamide and mitomycin C induce interstrand crosslinks (Deans and 
West, 2011). However, there is no evidence in current literature for direct UV-induced 
interstrand lesions. Since separation of the DNA double helix is essential for replication and 
transcription, interstrand lesions are deemed extremely toxic and usually irreversible. In 
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comparison, intrastrand crosslinks may be bypassed by some DNA polymerases, thus rendering 
them less toxic (Deans and West, 2011). Furthermore, repair of intrastrand crosslinks may be 
facilitated by the electronically favorable cyclic delocalization and resonance of the aromatic 
ring on DNA bases. While some information from the repair mechanisms of interstrand lesions is 
still missing, we know that interstrand lesion repair involves a complex coordination of 
nucleotide excision repair, homologous recombination and translesion synthesis, as well as the 
suppression of non-homologous end joining (Andreassen and Ren, 2009; Deans and West, 
2011).  
APPROACH 
Aim 1: Identify new UV-induced lesions, especially the more genotoxic interstrand DNA 
lesions in order to provide significant insights for a causative link between UV radiation 
and melanoma. 
Methodology 1: To pursue the first aim, we (a) used HPLC-MS/MS technology to identify UV-
induced DNA adducts in various mouse models of pigmentation. For characterizing unique 
adducts, we used a novel Mass Tag Profiling methodology that has been recently developed by 
the Giese lab, our collaborators at the Northeastern University School of Pharmacy. I received 
mass spectrometry training and performed all experiments under supervision at their extensive 
HPLC and mass spectrometry facility. In brief, the Mass Tag Profiling methodology is as 
follows: Once DNA was extracted via Qiagen gravity-flow columns (based on prior experiments 
with cells and mouse skins, anion-exchange resin in QIAGEN-tips seemed more effective for 
purification and extraction of DNA from tissue samples than silica-membrane-based spin-
columns), it was digested by to the nucleotide level, filtered, separated by HPLC, labeled with a 
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d0, d4, or d0/d4 benzoylhistamine tag, further filtered to remove excess tag, deposited with 
alpha-cyano matrix on a MALDI-plate, and finally analyzed through a MALDI-TOF machine. 
Due to the fact that our tagging labels only bound to free phosphates in a 1:1 stoichiometry, we 
(b) used variable tagging (heavy/light/mix) to determine inter- versus intrastrand-bonded nucleic 
acid adducts. Furthermore, we (c) tested UV-induction on a variety of oligonucleotides 
(combination of different dNTPs, methylation/other modifications of dNTPs) for structural 
insights into the DNA adducts. For a more comprehensive understanding of radiation-induced 
DNA lesions, we (d) measured the quantity of lesion induction under a range of wavelengths 
(UVA, UVB, gamma) and irradiation doses. 
Hypothesis 1: We believe that heretofore unknown lesions—specifically, heretofore unknown 
novel interstrand DNA adducts—may represent a new UVB-signature lesion that can be linked 
to melanoma.  
Preliminary Data 1: We utilized a new chemical approach to the analysis of genomic DNA after 
UV irradiation and discovered a relatively common occurrence of interstrand crosslinked DNA. 
Multiple follow-up studies have been carried out which have confirmed its existence, its 
intrastrand nature (both using the benzoylhistamine tag, and the oligos where the two crosslinked 
bases were only on opposite strands).  
Initial screening for novel UV-induced DNA adducts was performed by HPLC-MS/MS 
on purified DNA from UV-irradiated skin of red-haired (e/e, frameshift mutation in Mc1r gene) 
or albino (c/c, mutation in the tyrosinase gene) K14-XPC(-/-) mice; controls were also provided 
(initial samples supplied by a fellow labmate, Dr. K. Robinson). In the UV-treated samples only, 
MassSpec profiling showed two novel, unique peaks (at 794.143 and 808.165 post-tagging) from 
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the HPLC fraction collected right after the Cytosine (C) peak (Figure A3). This indicated that 
these two structures, hereafter referred to as the “794” and “808” peaks, consist of a Cytosine-
complex. Further fragmentation (MS/MS profiling) revealed that (1) the abundance of PO3 and 
PO4 in the MS/MS of the 808peak and 794 peak indicates that these are interstrand complexes 
(see “Potential Pitfalls and Strategies” below), also verified by oligonucleotide experiments with 
single cytosines; (2) MS and MS/MS profiling suggests that the complexes each consist of 2 
cytosines; (3) position of complexes on the UV-spectrographs (relative too position of Cytosine-
peak) further suggests 2-cytosine-adducts;  (4) fragmentation of the complexes at their loss-of-
tag m/z precursor ratios is in accordance with the above observations, suggesting that this is not 
an artifact of the MassTag Profiling methodology; (5) both complexes were abundantly present 
in e/e and c/c UVB-irradiated DNA (on the order of 30ppm, about 1/5 the level of CPD 
induction), but completely absent from unirradiated controls as well as from UVA-irradiations, 
suggesting a UVB-only adduct induction.  
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Figure A3: Induction of interstrand cytosine adducts by UVB irradiation (on red (e/e) 
mouse skin); d0 tag = UVB; d4 tag= control. 
 
Anticipated Results 1: With the help of newly developed Mass Tag Profiling methodology with 
our collaborators, initial HPLC-MS/MS profiles from UVB-irradiated mouse skins led us to 
suspect that we found unique UV-induced interstrand adducts in vivo, which have not been 
previously identified/ reported in literature. We expected re-testing of DNA from replicate skin 
samples and from skin cells in culture to concur with the above data. We expected further 
experiments on oligonucleotides to reveal clues about preferences of adduct induction (e.g., tight 
GCGCGC sequences might be too bulky for efficient induction, as might certain base 
modifications), which would enable us to propose mechanisms for UV-induced adduct 
formation. Furthermore, given the time- and resource-consuming nature of mass spectrometry 
preparations/experiments, we expected to develop molecular biology assays for distinguishing 
our novel cytosine interstrand adducts from other lesions (e.g. by fluorescently-tagged 
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denaturing gel shift assays that would distinguish between inter- versus intrastrand adducts. 
Given the usually highly genotoxic nature of interstrand lesions, our findings could have a 
significant impact on our understanding of UV-induced DNA damage and cellular repair.        
Potential Pitfalls and Strategies: 
Our 808 and 794 peaks have unique MS signatures, thus reducing the likelihood of false 
positives and helping to ensure the accuracy of our abundance calculations.  
MS/MS fragmentation reveals abundant free phosphates in the tagged adduct, which is 
only feasible if the adduct is interstrand. Our unique Mass Tag Profiling methodology, with a 
benzyolhistamine tag on any free phosphate, enabled us to uniquely distinguish between inter- 
and intrastrand crosslinked complexes. 
Our reciprocal labeling with d0, d4, d0/d4 tags enabled us to doubly confirm the identity of 
any peaks of interest on a mass spectrometry profile. Loss-of-tag profiling then let us rule out 
artificial peaks from the alpha-cyano matrix. 
We always incorporated a 575 internal standard uniformly into our MALDI depositions; 
furthermore, we used the widely-known UVB-induced CPD dimer as another standard for 
measuring and quantifying peak intensities into parts per million abundance values.  
To help ensure replicable HPLC fraction collections, we thoroughly flushed the 
instrument with 100% acetonitrile and run a blank sample at 0.05% acetonitrile to check for trace 
peaks on the UV spectrograph. All collections started and ended at a predetermined threshold 
intensity. We re-run samples if the spectrographs do not line up. Furthermore, we deposited at 
least 400 spots per fraction on the MALDI plate to avoid any missed signals.   
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To prevent any heat-induced artificiality in our oligo work, we performed oligo 
irradiations on an ice bucket and pause every 20min. Thermometer readings indicated no 
increase in temperatures during irradiations, and the volume of samples remained consistent 
(minimal evaporation: 1ul/100ul loss after 1 hour irradiation=3000mJ/cm2 UVB). Furthermore, 
mass spectrometry profiles of UV-irradiated oligos under ice and at room temperature showed 
the same 808 peak profiling.  
Aim 2: Characterize the novel interstrand lesions and their repair kinetics in order to 
identify new UV-signature mutations for illuminating molecular mechanisms behind 
melanoma pathogenesis.  
Methodology 2: To pursue the second aim, we (a) used organic synthesis to validate our 
hypothesized structures; with well-developed structure hypotheses, we could better develop 
diagnostic tools for studying novel adducts. To accomplish this task, we planned to use boronic 
acid conjugates of cytosine and cytosine halides for a Suzuki coupling reaction to give the 
regioisomers of our hypothesized structure (Figure A4).  
 
Figure A4: Hypothesized structure of interstrand adduct. 
 
Illustration	  1
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(b) Together with flow-cytometry-based studies of repair kinetics and modified shuttle 
vector mutagenesis assays, we could identify the signature mutations of these novel UV-induced 
adducts, which (as suggested by preliminary analyses) could be aligned to genomic mutation 
patterns from melanoma databanks, thus helping us understand UV-induced melanoma 
pathogenesis. More specifically, flow-cytometry-based studies of repair kinetics would be 
performed by harvesting primary skin cells (keratinocytes) from culture, then sorted into live 
versus dead populations, and quantified for the amount of adducts pre- and post-irradiation at 
various timepoints via HPLC-MS/MS to establish the efficiency/rate of repair.  
(c) Furthermore, we aim to identify key players in the repair of interstrand lesions via 
studying DNA repair-deficient cell models.  
(d) We could adapt current shuttle vector mutagenesis assays as follows: After UVB-
irradiating GFP plasmids, we would remove other photoproducts via CPD- and 6,4-photolyases, 
transfect into skin cells, track and extract DNA post-repair, sequence/analyze original adduct 
sites to determine mutations. We would compare these results with bioinformatical analysis for 
mutation hotspots in melanomas through a genomics collaboration with the Broad Institute, with 
the hope of linking prominent mutations in melanomas (when matched to normal) to erroneous 
repair of our UVB-induced interstrand crossslinked adducts, thus revealing a new UVB-signature 
mutation(s) that is unique to melanomas.  
Hypothesis 2: Due to the genotoxity of interstrand lesions, we believed repair of our interstrand 
adducts to be error-prone (new UVB-signature mutation) and/or inefficient (induced cell death). 
We strove to demonstrate that cellular repair of novel interstrand DNA lesions leads to cellular 
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DNA mutations (different from known photoproducts) that show high incidence in melanomas 
but not other non-skin cancers (such as ovarian, colorectal).  
Preliminary Data 2: Initial repair kinetics experiments on mice (sacrificing and extracting UVB-
irradiated mice at various timepoints) have indicated that most of the UVB-induced interstrand 
cytosine adducts disappear within 24hr (Figure A5). In our very recently formed genomics 
collaboration with the Broad Institute, we examined mutation patterns for melanomas (matched 
to normal) and ovarian cancer (matched to normal as well). We focused on trinucleotide contexts 
where any subsequent mutations could not be explained by 6.4-photoproducts or CPD dimers 
(that is, pyrimidine-dimer-independent context would be of purine-Cytosine-purine type). We 
found 2 groups of “hot” mutations (i.e., high incidence in melanomas), as follows: 1. C->T 
transitions (even in purine-Cytosine-purine context, thus not attributed to CPD, 6,4-
photoproducts); 2. C->G transversions. Due to the frequency of natural C->T transitions at CpG 
islands, we chose to focus on the 2nd group of “hot” mutations in melanomas, the C->G 
transversions (which, one could argue, would constitute a more significant mutation solely due to 
the large structural substitution and electronic repulsions between the guanine bases). One of our 
goals was to link these C->G mutations in melanomas to erroneous repair of our UVB-induced 
interstrand crosslinked cytosine lesions.   
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Figure A5: Quantity of UVB-induced interstrand cytosine adducts (peaks indicated by orange 
horizontal lines) significantly declines by 24hr (compare heights of overlapping peaks). 
 
Anticipated Results 2: We expected the mass spectrometry profiles of synthesized adducts to 
match that from our in vivo mouse experiments (and oligo experiments), thus further supporting 
our hypothesized adduct structure (Figure A4). Together with flow-cytometry-based studies of 
repair kinetics and modified shuttle vector mutagenesis assays, we could identify the signature 
mutations of these novel UV-induced adducts, which (as suggested by preliminary analyses) 
could be aligned to genomic mutation patterns from melanoma databanks, thus helping us 
understand UV-induced melanoma pathogenesis.   
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Potential Pitfalls and Strategies:  
We were aware that our results are only as good as the technical limitations of our 
instruments. Thus, at all steps, especially repair experiments that were measuring declining 
quantities, we aimed to magnify our signals via GFP/fluorescent/double-labeling/other 
tagging/internal controls.   
We recently became aware that the starting materials for our proposed organic synthesis 
experiment (for structural characterization) may not be available due to thermodynamic 
instability of boronic-acid-conjugates of cytosine. However, we could circumvent this problem 
by performing the Suzuki coupling reaction on uracil instead. We would then perform 
deamination of our interstrand cytosine adducts isolated from in vivo samples (via bisulfite 
treatment) to give equivalent uracil-interstrand-adducts, run Mass Tag Profiling, and compare 
with mass spec profiling from synthesized uracil adducts to validate our hypothesized adduct 
structures.  
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